About this trial
This platform trial aims to evaluate the effectiveness of different messaging strategies within a MyChart messaging program for research recruitment. MyChart is a patient portal system within the Electronic Medical Record (EMR), and messages can be sent directly to patients about research opportunities.
Eligibility criteria
Qualifiers
All studies using the MyChart recruitment service are eligible, including both clinical trials and observational studies.
Not using MyChart for recruitment.
At least 500 messages sent, 125 for each arm
All patients receiving messages via MyChart will be included
Disqualifiers
Minor
Excluded from primary study that is recruiting participants.
Trial design
Treatments tested in this trial
- Baseline (control) message
- Positively-valenced message
- Payment-inclusive message
- Positively-valenced, payment-inclusive message
Treatment groups
Sponsors and collaborators
Emory University
Lead sponsor
American Heart Association
Collaborator
Georgia Clinical & Translational Science Alliance
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator